L. Yperzeele
Key design elements of successful acute ischemic stroke treatment trials
Yperzeele, L.; Shoamanesh, A.; Venugopalan, Y. V.; Chapman, S.; Mazya, M. V.; Charalambous, M.; Caso, V.; Hacke, W.; Bath, P. M.; Koltsov, I.
Authors
A. Shoamanesh
Y. V. Venugopalan
S. Chapman
M. V. Mazya
M. Charalambous
V. Caso
W. Hacke
Professor PHILIP BATH philip.bath@nottingham.ac.uk
STROKE ASSOCIATION PROFESSOR OF STROKE MEDICINE
I. Koltsov
Abstract
Purpose: We review key design elements of positive randomized controlled trials (RCTs) in acute ischemic stroke (AIS) treatment and summarize their main characteristics. Method: We searched Medline, Pubmed and Cochrane databases for positive RCTs in AIS treatment. Trials were included if (1) they had a randomized controlled design, with (at least partial) blinding for endpoints, (2) they tested against placebo (or on top of standard therapy in a superiority design) or against approved therapy; (3) the protocol was registered and/or published before trial termination and unblinding (if required at study commencement); (4) the primary endpoint was positive in the intention to treat analysis; and (5) the study findings led to approval of the investigational product and/or high ranked recommendations. A topical approach was used, therefore the findings were summarized as a narrative review. Findings: Seventeen positive RCTs met the inclusion criteria. The majority of trials included less than 1000 patients (n = 15), had highly selective inclusion criteria (n = 16), used the modified Rankin score as a primary endpoint (n = 15) and had a frequentist design (n = 16). Trials tended to be national (n = 12), investigator-initiated and performed with public funding (n = 11). Discussion: Smaller but selective trials are useful to identify efficacy in a particular subgroup of stroke patients. It may also be of advantage to limit the number of participating countries and centers to avoid heterogeneity in stroke management and bureaucratic burden. Conclusion: The key characteristics of positive RCTs in AIS treatment described here may assist in the design of further trials investigating a single intervention with a potentially high effect size.
Citation
Yperzeele, L., Shoamanesh, A., Venugopalan, Y. V., Chapman, S., Mazya, M. V., Charalambous, M., Caso, V., Hacke, W., Bath, P. M., & Koltsov, I. (2023). Key design elements of successful acute ischemic stroke treatment trials. Neurological Research and Practice, 5(1), Article 1. https://doi.org/10.1186/s42466-022-00221-9
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 17, 2022 |
Online Publication Date | Jan 5, 2023 |
Publication Date | Jan 5, 2023 |
Deposit Date | Nov 4, 2022 |
Publicly Available Date | Jan 5, 2023 |
Journal | Neurological Research and Practice |
Electronic ISSN | 2524-3489 |
Publisher | BioMed Central |
Peer Reviewed | Peer Reviewed |
Volume | 5 |
Issue | 1 |
Article Number | 1 |
DOI | https://doi.org/10.1186/s42466-022-00221-9 |
Public URL | https://nottingham-repository.worktribe.com/output/13179941 |
Publisher URL | https://neurolrespract.biomedcentral.com/articles/10.1186/s42466-022-00221-9 |
Files
Key Design Elements
(822 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search